IP Library Granted Patent US 10,760,062
Granted Patent B2
US 10,760,062 · App. 15/579,415 · Granted Sep 1, 2020

Biosynthesis of phenylpropanoids and phenylpropanoid derivatives

Inventors: Michael Naesby (Huningue, FR); Ernesto Simón Vecilla (Glostrup, DK); Michael Eichenberger (Basel, CH); Beata Joanna Lehka (Valby Copenhagen, DK); Walden Emil Bjørn-Yoshimoto (Reinach, CH); Niels Bjerg Jensen (Kastrup, DK)
Assignee: EVOLVA SA
C12N9/001C12N9/002C12N9/1029C12N9/1037C12N15/81C12P7/22C12P7/26C12P19/44C12Y103/01038C12Y103/01094C12Y203/01095
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,760,062
App. No.
15/579,415
Granted
Sep 1, 2020
Kind
B2
Abstract

Provided herein are methods and compositions for producing phenylpropanoid derivatives, such as chalcones and stilbenes, and dihydrophenylpropanoid derivatives, such as dihydrochalcones and dihydrostilbenes, in microorganisms. In particular, the disclosure provides recombinant microorganisms and methods of use thereof for producing phenylpropanoid derivative compounds and dihydrophenylpropanoid derivative compounds.

Claims (94)

1. A method of producing a chalcone compound or a stilbene compound, comprising growing a yeast cell capable of producing a phenylpropanoid or phenylpropanoid derivative compound in a culture medium,

wherein said chalcone compound or stilbene compound is synthesized by the yeast cell, and

wherein the yeast cell comprises a gene encoding a double-bond reductase polypeptide, wherein expression of the gene or activity of the double-bond reductase polypeptide encoded thereby is reduced or eliminated, and wherein the double-bond reductase polypeptide:

(i) comprises SEQ ID NO: 22;

(ii) comprises a polypeptide with at least 90% identity to SEQ ID NO: 22;

(iii) comprises SEQ ID NO: 26;

(iv) comprises a polypeptide with at least 90% identity to SEQ ID NO: 26;

(v) is encoded by a nucleic acid sequence comprising SEQ ID NO: 7;

(vi) is encoded by a nucleic acid sequence comprising a sequence with at least 90% identity to SEQ ID NO: 7;

(vii) is encoded by a nucleic acid sequence comprising SEQ ID NO: 43; or

(viii) is encoded by a nucleic acid sequence comprising a sequence with at least 90% identity to SEQ ID NO: 43.

2. The method of claim 1 , wherein the double-bond reductase polypeptide is S. cerevisiae trans-2-enoyl-CoA reductase TSC13 or S. cerevisiae DFG10.

3. The method of claim 1 , wherein the yeast cell is a recombinant yeast cell and comprises a recombinant gene encoding an enzyme that partially or completely complements the function of the double-bond reductase polypeptide, wherein the recombinant gene:

(a) is any one of SEQ ID NOs: 94-96;

(b) is a nucleotide sequence with at least 90% identity to any one of SEQ ID NOs: 94-96;

(c) encodes any one of SEQ ID NOs: 65-67; or

(d) encodes a polypeptide with at least 90% identity to any one of SEQ ID NOs: 65-67;

and wherein the method further comprises growing the recombinant yeast cell under conditions in which the recombinant gene encoding an anzyme that partially or completelty ocmplements the function of the double-bond reductase polypeptide is expressed.

4. The method of claim 1 , wherein the yeast cell is a recombinant yeast cell and comprises a recombinant gene encoding a polyketide synthase Type III polypeptide, and wherein the method further comprises growing the recombinant yeast cell under conditions in which the recombinant gene encoding the polyketide synthase Type III polypeptide is expressed.

5. The method of claim 4 , wherein the polyketide synthase Type III polypeptide is:

(a) a chalcone synthase polypeptide; or

(b) a stilbene synthase polypeptide.

6. The method of claim 5 , wherein the polyketide synthase Type III polypeptide:

(i) is encoded by a nucleic acid sequence comprising SEQ ID NO: 4;

(ii) is encoded by a nucleic acid sequence comprising a sequence with at least 90% identity to SEQ ID NO: 4;

(iii) comprises SEQ ID NO: 19;

(iv) comprises a polypeptide sequence with at least 90% identity to SEQ ID NO: 19;

(v) is encoded by a nucleic acid sequence comprising SEQ ID NO: 23;

(vi) is encoded by a nucleic acid sequence comprising a sequence with at least 90% identity to SEQ ID NO: 23;

(vii) comprises SEQ ID NO: 24; or

(viii) comprises a polypeptide sequence with at least 90% identity to SEQ ID NO: 24.

7. The method of claim 4 , wherein the recombinant yeast cell further comprises one or more of:

(a) a recombinant gene encoding a phenylalanine ammonia lyase polypeptide;

(b) a recombinant gene encoding a cinnamate 4-hydroxylase polypeptide;

(c) a recombinant gene encoding a 4-coumarate-CoA ligase polypeptide;

(d) a recombinant gene encoding a cytochrome p450 polypeptide; or

(e) a recombinant gene encoding a chalcone isomerase polypeptide.

8. The method of claim 7 , wherein:

(a) the recombinant gene encoding the phenylalanine ammonia lyase polypeptide:

(i) comprises SEQ ID NO: 1;

(ii) comprises a nucleotide sequence with at least 90% identity to SEQ ID NO: 1;

(iii) encodes a polypeptide comprising SEQ ID NO: 16; or

(iv) encodes a polypeptide with at least 90% identity to SEQ ID NO: 16;

(b) the recombinant gene encoding the cinnamate 4-hydroxylase polypeptide:

(i) comprises SEQ ID NO: 2;

(ii) comprises a nucleotide sequence with at least 90% identity to SEQ ID NO: 2;

(iii) encodes a polypeptide comprising SEQ ID NO: 17; or

(iv) encodes a polypeptide with at least 90% identity to SEQ ID NO: 17;

(c) the recombinant gene encoding the 4-coumarate-CoA ligase polypeptide:

(i) comprises SEQ ID NO: 3;

(ii) comprises a nucleotide sequence with at least 90% identity to SEQ ID NO: 3;

(iii) encodes a polypeptide comprising SEQ ID NO: 18; or

(iv) encodes a polypeptide with at least 90% identity to SEQ ID NO: 18;

(d) the recombinant gene encoding the cytochrome p450 polypeptide:

(i) comprises SEQ ID NO: 6;

(ii) comprises a nucleotide sequence with at least 90% identity to SEQ ID NO: 6;

(iii) encodes a polypeptide comprising SEQ ID NO: 21; or

(iv) encodes a polypeptide with at least 90% identity to SEQ ID NO: 21; or

(e) the recombinant gene encoding the chalcone isomerase polypeptide:

(i) comprises any one of SEQ ID NOS: 80-86;

(ii) comprises a nucleotide sequence with at least 90% identity to any one of SEQ ID NOS: 80-86;

(iii) encodes a polypeptide comprising any one of SEQ ID NOS: 87-93; or

(iv) encodes a polypeptide a polypeptide with at least 90% identity to any one of SEQ ID NOS: 87-93.

9. The method of claim 1 , wherein the phenylpropanoid compound is cinnamic acid or coumaric acid.

10. The method of claim 1 , wherein the phenylpropanoid derivative compound is a chalcone compound or a stilbenoid compound.

11. The method of claim 10 , wherein the stilbenoid compound is resveratrol.

12. The method of claim 1 , wherein the yeast cell is a Saccharomyces cerevisiae cell, a Schizosaccharomyces pombe cell, a Yarrowia lipolytica cell, a Candida glabrata cell, a Ashbya gossypii cell, a Cyberlindnera jadinii cell, a Pichia pastoris cell, a Kluyveromyces lactis cell, a Hansenula polymorpha cell, a Candida boidinii cell, an Arxula adeninivorans cell, a Xanthophyllomyces dendrorhous cell, or a Candida albicans cell.

13. The method of claim 1 , wherein the chalcone compound or stilbene compound is a compound of formula (III):

or a pharmaceutically acceptable salt thereof, wherein

A is a bond or C═O;

n is an integer 0, 1, 2, 3, or 4;

R is hydrogen when is a double bond, or R and R 5 together with the atoms to which they are attached form a 6-member heterocyclyl when A is C═O and is a single bond;

R 1 is hydrogen or —OR 11 ;

wherein each R 11 is independently hydrogen, C 1 -C 6 alkyl, or glycosyl;

R 2 is hydrogen, —OR 11 , C 1 -C 12 alkyl, or C 2 -C 12 alkenyl, wherein alkyl and alkenyl are optionally substituted with one or more R 7 ;

or R 2 and R 6 together with the atoms to which they are attached form a 5- to 7-member heterocyclyl optionally substituted with one or more R 7 groups;

or R 2 and R 4 together with the atoms to which they are attached form a 5- to 7-member heterocyclyl optionally substituted with one or more R 7 groups;

R 3 is independently selected from nitro, C 1 -C 6 alkyl, C 2 -C 6 alkenyl, C 1 -C 6 haloalkyl, C 1 -C 6 hydroxyalkyl, —OR 12 , —N(R 12 ) 2 , —C(O)R 12 , —C(O)OR 12 , —C(O)N(R 12 ) 2 , and —S(O) 2 R 12 , wherein each R 12 is independently hydrogen or C 1 -C 6 alkyl;

R 4 is hydrogen, —OR 11 , C 1 -C 12 alkyl, or C 2 -C 12 alkenyl, wherein alkyl and alkenyl are optionally substituted with one or more R 7 ;

or R 4 and R 2 together with the atoms to which they are attached form a 5- to 7-member heterocyclyl optionally substituted with one or more R 7 groups;

R 5 is hydrogen, —OR 11 , —C(O)OR 10 , or —C(O)N(R 10 ) 2 , wherein each R 10 is independently hydrogen or C 1 -C 6 alkyl; and

R 6 is hydrogen, C 1 -C 6 alkyl, C 2 -C 6 alkenyl, —OR 11 , —N(R 10 ) 2 , —C(O)R 10 , —C(O)OR 10 , or —C(O)N(R 10 ) 2 , wherein alkyl and alkenyl are optionally substituted with one or more R 8 ; or R 6 and R 2 together with the atoms to which they are attached form a 5- to 7-member heterocyclyl optionally substituted with one or more R 8 groups;

each R 7 and R 8 is independently halogen, cyano, nitro, C 1 -C 6 alkyl, C 2 -C 6 alkenyl, C 1 -C 6 haloalkyl, C 1 -C 6 hydroxyalkyl, —OR 13 , —SR 13 , —N(R 13 ) 2 , —C(O)R 13 , —C(O)OR 13 , —C(O)N(R 13 ) 2 , or —S(O) 2 R 13 , wherein each R 13 is independently hydrogen or C 1 -C 6 alkyl.

14. The method of claim 1 , further comprising harvesting said chalcone compound or stilbene compound.

15. The method of claim 1 , further comprising isolating said chalcone compound or stilbene compound.

16. The method of claim 1 , wherein the double-bond reductase polypeptide:

(i) comprises SEQ ID NO: 22;

(ii) comprises a polypeptide with at least 90% identity to SEQ ID NO: 22;

(iii) is encoded by a nucleic acid sequence comprising SEQ ID NO: 7; or

(iv) is encoded by a nucleic acid sequence comprising a sequence with at least 90% identity to SEQ ID NO: 7.

17. The method of claim 1 , wherein said chalcone compound or stilbene compound is resveratrol.

18. The method of claim 17 , further comprising isolating the resveratrol.

19. The method of claim 16 , wherein said chalcone compound or stilbene compound is resveratrol.

20. The method of claim 19 , further comprising isolating the resveratrol.

Assignments (1)
MERGER Recorded Jun 27, 2024
From: EVOLVA SA
To: DANSTAR FERMENT AG
Reel/Frame 067863/0857 →
Continuity (4)
Provisional Application 62171742 · Jun 5, 2015
Provisional Application 62331023 · May 3, 2016
Provisional Application 62337576 · May 17, 2016
Related Publication 20180142216A1 · May 24, 2018
Cited By (1)
US 12,241,109